公众号 / 文章复苏、休克与脓毒症心脑血管急症

面向急诊医师的COVID-19临床更新:院外与院内心脏骤停

Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings.
PubMed 文献 · Am J Emerg Med · 2022-04-27
一句话结论COVID-19疫情期间院内外心脏骤停发生率升高、多数生存指标下降,但医护人员在规范使用个人防护装备下 contagion 风险低,接种加强疫苗可提供进一步保护。

该文是面向急诊医师的COVID-19系列更新之一,聚焦院外与院内心脏骤停。截至2022年2月23日全球累计4.35亿感染、590万死亡(1.4%)。数据显示院内外心脏骤停发生率均升高,多数生存指标相应下降;院外旁观者初始施救频率下降,不可电击初始心律增多。胸外按压等操作虽属气溶胶生成操作,但在规范使用个人防护装备下医护人员感染风险低,接种加强疫苗可提供进一步保护。疫情对心脏骤停救治链造成不利影响。

要点

  • 截至2022年2月23日,全球COVID-19累计4.35亿感染、590万死亡,病死率1.4%。
  • 数据显示院外与院内心脏骤停发生率均升高,多数生存指标相应下降。
  • 院外旁观者初始施救频率下降,不可电击初始心律增多。
  • 胸外按压等属气溶胶生成操作,但规范使用个人防护装备下医护人员感染风险低。
  • 接种加强疫苗为参与心脏骤停复苏的医护人员提供进一步保护。

适用人群与场景

  • 院外与院内心脏骤停患者,以及参与其复苏的急诊与重症医护人员。

研究设计与关键结果

  • 截至2022年2月23日,全球COVID-19累计4.35亿感染、590万死亡(1.4%)。
  • 当前数据提示院外和院内心脏骤停发生率均升高,多数生存指标相应下降。
  • 院外旁观者初始施救频率下降,不可电击初始心脏骤停心律增多。
  • 胸外按压等多项干预属气溶胶生成操作,但在规范使用个人防护装备下医护人员感染风险低。
  • 接种加强疫苗为参与心脏骤停复苏的医护人员提供进一步保护。
  • 疫情对心脏骤停救治链造成不利影响。

证据类型、等级与局限

  • 综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 胸外按压等属气溶胶生成操作,但规范使用个人防护装备下医护人员感染风险低。
  • 接种加强疫苗可为参与心脏骤停复苏的医护人员提供进一步保护。
  • 疫情下院外旁观者初始施救频率下降、不可电击心律增多,救治链受到不利影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases worldwide. As the pandemic has progressed, the understanding of this disease has evolved. Its impact on the health and welfare of the human population is significant; its impact on the delivery of healthcare is also considerable.

OBJECTIVE: This article is another paper in a series addressing COVID-19-related updates to emergency clinicians on the management of COVID-19 patients with cardiac arrest.

DISCUSSION: COVID-19 has resulted in significant morbidity and mortality worldwide. From a global perspective, as of February 23, 2022, 435 million infections have been noted with 5.9 million deaths (1.4%). Current data suggest an increase in the occurrence of cardiac arrest, both in the outpatient and inpatient settings, with corresponding reductions in most survival metrics. The frequency of out-of-hospital lay provider initial care has decreased while non-shockable initial cardiac arrest rhythms have increased. While many interventions, including chest compressions, are aerosol-generating procedures, the risk of contagion to healthcare personnel is low, assuming appropriate personal protective equipment is used; vaccination with boosting provides further protection against contagion for the healthcare personnel involved in cardiac arrest resuscitation. The burden of the COVID-19 pandemic on the delivery of cardiac arrest care is considerable and, despite multiple efforts, has adversely impacted the chain of survival.

CONCLUSION: This review provides a focused update of cardiac arrest in the setting of COVID-19 for emergency clinicians.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Brady WJ, Chavez S, Gottlieb M, et al. Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings. Am J Emerg Med. 2022. PMID: 35561501. doi:10.1016/j.ajem.2022.04.031

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。